Sign In
Buy NBIX
$165.11
+10.27 (+6.63%)
At Close: Jun 03, 2026
Charting a bull-trend whipsaw, S&P 500 nails next resistance
04:35pm, Tuesday, 14'th Jul 2020
Technically speaking, the U.S. benchmarks have registered a mid-July market whipsaw, writes Michael Ashbaugh, pressured at least briefly amid the month’s...
Did Hedge Funds Make The Right Call On Neurocrine Biosciences, Inc. (NBIX)?
11:16pm, Monday, 13'th Jul 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2020 Financial Results
08:01pm, Monday, 13'th Jul 2020
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it will report second quarter financial results after the Nasdaq market closes on Monday, August 3, 2020. Neurocrine will then host a c
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
12:00am, Friday, 10'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 9)
Affimed NV (NASDAQ: AFMD)...
Axa Has $6.94 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
05:26am, Monday, 06'th Jul 2020
Axa boosted its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) by 8.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Engineers Gate Manager LP
07:24am, Saturday, 04'th Jul 2020
Engineers Gate Manager LP cut its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) by 88.8% during the first quarter, according to its most recent Form 13F filing with the Securities a
Philippines probes deadly police shooting of soldiers
04:37pm, Thursday, 02'nd Jul 2020
MANILA (AFP): Philippine authorities are investigating the deaths of four soldiers shot by police in the country's restive south, with the defence minister vowing Thursday (July 2) to "get to the bott
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Pfizer (NYSE: PFE) - Markets
03:52pm, Thursday, 02'nd Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurocrine (NBIX
Nasdaq's $1.2trn biotech index draws Europe's coronavirus vaccine hunters - LearnBonds.com
12:33pm, Wednesday, 01'st Jul 2020
Pharma Mar to become the latest company with US IPO interest as it prepares to join Nasdaq's $1.2 trillion biotech index on investor interest. Read more.
From Parkinson's to peanut allergy, pandemic puts brakes on new drugs
11:50am, Wednesday, 01'st Jul 2020
Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters revi
FOCUS-From Parkinson's to peanut allergy, pandemic puts brakes on new drugs
11:00am, Wednesday, 01'st Jul 2020
Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters revi
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Guggenheim Capital LLC
09:08am, Wednesday, 01'st Jul 2020
Guggenheim Capital LLC lessened its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) by 18.0% during the first quarter, according to the company in its most recent disclosure with the Sec
From Parkinson's to peanut allergy, pandemic puts brakes on new drugs
12:00am, Wednesday, 01'st Jul 2020
From Parkinson's to peanut allergy, pandemic puts brakes on new drugs
Crestchic’s load banks support fire prevention strategies and ageing energy infrastructure in the US - DirectorsTalk
08:00am, Tuesday, 30'th Jun 2020
Due to ageing electrical distribution systems in the United States, sections of the power grids are being switched off for repairs to mitigate wildfire risks. With parts of the grid turned off, United
Neurocrine Biosciences (NASDAQ:NBIX) Downgraded to Neutral at Goldman Sachs Group
04:32am, Tuesday, 30'th Jun 2020
Goldman Sachs Group cut shares of Neurocrine Biosciences (NASDAQ:NBIX) from a buy rating to a neutral rating in a report published on Monday, BenzingaRatingsTable reports. They currently have $135.00
